Showing results (191-200 of 435) with videos related to

Sort By:
Pageof 44
The Journal of General Virology|September 9, 2011
Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control studyPontus Naucler, Flora Mabota da Costa, Joao Leopoldo da Costa, et al.
The Journal of Investigative Dermatology|July 13, 2004
High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumorsOla Forslund, Bernt Lindelöf, Eva Hradil, et al.
International Journal of Cancer|August 15, 2024
Nationwide registry-based trial of risk-stratified cervical screeningLaila Sara Arroyo Mühr, Jiangrong Wang, Sadaf S Hassan, et al.
Vaccine|September 5, 2006
Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an updateSonia R Pagliusi, Joakim Dillner, Michael Pawlita, et al.
European Journal of Public Health|January 23, 2024
Divergent effects of switching from cytology to HPV-based screening in the Nordic countriesVeli-Matti Partanen, Joakim Dillner, Ameli Tropé, et al.
Scientific Reports|July 25, 2014
Deep sequencing extends the diversity of human papillomaviruses in human skinDavit Bzhalava, Laila Sara Arroyo Mühr, Camilla Lagheden, et al.
Plos One|July 24, 2020
Exposure to polychlorinated compounds and cryptorchidism; A nested case-control studyJonatan Axelsson, Kristin Scott, Joakim Dillner, et al.
International Journal of Cancer|November 11, 2010
Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control studyLena Silfverdal, Levent Kemetli, Pär Sparén, et al.
American Journal of Obstetrics and Gynecology|June 30, 2009
Risk of invasive cervical cancer in relation to management of abnormal Pap smear resultsLena Silfverdal, Levent Kemetli, Bengt Andrae, et al.
International Journal of Cancer|June 2, 2025
Randomised trial on treatment of vaginal high-grade squamous intraepithelial lesion: Self-administered vaginal imiquimod and laser vaporisationMari Kiviharju, Annika Riska, Ilkka Kalliala, et al.
Pageof 44